Inhibitory effect of sesamolin on melanogenesis in B16F10 cells by in vitro and in silico analysis.

CONCLUSION: Sesamolin is a good candidate for melanogenic inhibition. However, sesamolin was predicted as a weak sensitizer by Derek EC3 prediction. It is necessary to confirm the safety of sesamolin as a cosmetic material in a biological skin toxicity experiment. PMID: 31612825 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31612825?dopt=Abstract

Source: Current Pharmaceutical Biotechnology - October 10, 2019 Category: Biotechnology Authors: Baek SH, Kang MG, Parka D Tags: Curr Pharm Biotechnol Source Type: research